Berkshire also disclosed it has stopped selling shares of Apple, which remained its largest common stock investment at $75.1 billion.

Citi analysts adjusted their outlook on CRISPR Therapeutics (NASDAQ:CRSP) stock, reducing the price target to $82 from $89 while maintaining a Buy rating. The stock, which has shown significant ...

Credicorp Ltd (NYSE:BAP), a leading financial services holding company with a market capitalization of $14.75 billion and a "GOOD" financial health rating according to InvestingPro, has filed a Form 6 ...

After the latest earnings report from tractor maker Deere, Citi analyst Kyle Menges raised his price target to $480 from $430, but kept a Hold rating.

We recently published a list of 12 Most Promising Energy Stocks According to Analysts. In this article, we are going to take ...

The initial response to the emergence of generative artificial intelligence (GenAI) at a number of global banks was a ...

Many or all of the products on this page are from partners who compensate us when you click to or take an action on their website, but this does not influence our evaluations or ratings. Our ...

Nvidia reported in an SEC filing disclosed today that it had reduced its investment in Arm by about 44% in the fourth quarter ...

Citigroup is exploring crypto custody services, joining major banks in expanding digital asset offerings amid regulatory ...

Intel early Friday was on track to notch its best weeklong stretch in nearly 40 years before the rally sputtered.

Citi raised the firm’s price target on eBay (EBAY) to $80 from $75 and keeps a Buy rating on the shares as part of a Q4 report preview. The ...